ESC Professional Premium Access

Effect of rivaroxaban monotherapy vs. combination with anti-platelet therapy in patients with atrial fibrillation and stable coronary artery disease across different body mass index categories

Congress Presentation

About the speaker

Doctor Masanobu Ishii

Kumamoto University Hospital, Kumamoto (Japan)
0 follower

4 more presentations in this session

Sodium-glucose co-transporter-2 inhibitors after acute myocardial infarction in type 2 diabetes patients: a population-based investigation from South Korea

Speaker: Doctor O. Kwon (Seoul, KR)

Thumbnail

Activation of mitochondrial telomerase reverses relative lymphopenia post myocardial infarction: results from the randomised, double-blinded TACTIC phase IIa pilot trial

Speaker: Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)

Thumbnail

Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Speaker: Doctor M. Pareek (Copenhagen, DK)

Thumbnail

Direct cost analysis of genetic testing for CYP2C19*2 and *3 loss of function variants in percutaneous coronary intervention patients

Speaker: Doctor S. Huxley (Rochester, US)

Thumbnail

Access the full session

Coronary artery disease - Pharmacotherapy 1

Speakers: Doctor M. Ishii, Doctor O. Kwon, Professor I. Spyridopoulos, Doctor M. Pareek, Doctor S. Huxley
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations